The Association of Reproductive Health Professionals (ARHP) and Planned Parenthood® Federation of America (PPFA) partneredon a comprehensive clinical education program, Managing HPV: A New Era in Patient Care. In tandem with the American Society for Colposcopy and Cervical Pathology (ASCCP), this program addresses current research and best practice recommendations concerning HPV testing, incorporating the HPV vaccine into prevention care, and treatment for complications of HPV including external genital warts and cervical cancer.
For more information about the program, please contact firstname.lastname@example.org or (202) 466-3825.
Despite being the most prevalent sexually transmitted infection (STI) in the United States, the majority of American men and women are unfamiliar with human papillomavirus (HPV).1 As a result, most people are unaware of the link between HPV and cervical cancer. The importance of educating the public about this connection is a frontline issue for the reproductive health care community. Clinicians recognize the importance of providing clients with the most recent developments in the fight against cervical cancer including the introduction of improved screening tools for HPV and the development of the HPV vaccine. ARHP and PPFA are committed to providing health care practitioners with progressive, medically-accurate information and advanced prevention, screening, and treatment options for HPV and cervical cancer.
Curriculum Learning Objectives
- Describe the significance of infection with HPV to patients including prevalence, mode of transmission, and long-term consequences
- Utilize national guidelines when screening patients for cervical and anal disease
- Apply evidence-based guidelines when managing women with abnormal screening tests
- Counsel patients regarding potential benefits and risks of vaccination against HPV
Intended Audience and Accreditation
The intended audience for the medical education activities is health care professionals—physicians, nurse practitioners, physician assistants, nurse midwives, pharmacists, researchers and others in the fields of ob/gyn and family practice. The public education activities have been developed for patients, the media, and the public.
The curriculum/live sessions, webinars, MobileCME, and Clinical Proceedings associated with this program are accredited for continuing medical education, nursing contact hours, pharmacology, and pharmacist credits.
This project is funded through independent education grants from a collaboration of pharmaceutical companies including GlaxoSmithKline, Graceway Pharmaceuticals, Merck and Co. Inc., and QIAGEN.
- Anhang R, Goodman A, Goldie SJ. HPV Communication: Review of Existing Research and Recommendations for Patient Education. CA Cancer J Clin. 2004;54;248-259.